• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

广泛性焦虑症抗体谱障碍:临床表型、免疫发病机制及治疗干预的进展

GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.

作者信息

Tsiortou Popianna, Alexopoulos Harry, Dalakas Marinos C

机构信息

Neuroimmunology Unit, Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Department of Neurology, Thomas Jefferson University, 900 Walnut Street, Philadelphia, PA 19107, USA; Neuroimmunology Unit, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Ther Adv Neurol Disord. 2021 Mar 30;14:17562864211003486. doi: 10.1177/17562864211003486. eCollection 2021.

DOI:10.1177/17562864211003486
PMID:33854562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8013924/
Abstract

Antibodies against glutamic acid decarboxylase (GAD), originally linked to stiff person syndrome (SPS), now denote the "" () that also include autoimmune epilepsy, limbic encephalitis, cerebellar ataxia and nystagmus with overlapping symptomatology highlighting autoimmune neuronal excitability disorders. The reasons for the clinical heterogeneity among GAD-antibody associated syndromes remain still unsettled, implicating variable susceptibility of GABAergic neurons to anti-GAD or other still unidentified autoantibodies. Although anti-GAD antibody titers do not correlate with clinical severity, very high serum titers, often associated with intrathecal synthesis of anti-GAD-specific IgG, point to effects of GAD or related autoantibodies within the central nervous system. It remains, however, uncertain what drives these antibodies, why they persist and whether they are disease markers or have pathogenic potential. The review, focused on these concerns, describes the widened clinical manifestations and overlapping features of all GAD-SD; addresses the importance of GAD antibody titers and potential significance of GAD epitopes; summarizes the biologic basis of autoimmune hyperexcitability; highlights the electrophysiological basis of reciprocal inhibition in muscle stiffness; and provides practical guidelines on symptomatic therapies with gamma-aminobutyric acid-enhancing drugs or various immunotherapies.

摘要

抗谷氨酸脱羧酶(GAD)抗体最初与僵人综合征(SPS)相关,现在代表了一组综合征,其中还包括自身免疫性癫痫、边缘性脑炎、小脑共济失调和眼球震颤,其重叠症状突出了自身免疫性神经元兴奋性障碍。GAD抗体相关综合征临床异质性的原因仍未明确,这暗示了GABA能神经元对抗GAD或其他仍未鉴定的自身抗体的易感性不同。尽管抗GAD抗体滴度与临床严重程度无关,但非常高的血清滴度,通常与抗GAD特异性IgG的鞘内合成有关,提示GAD或相关自身抗体在中枢神经系统内的作用。然而,仍不确定是什么驱动了这些抗体,它们为何持续存在,以及它们是疾病标志物还是具有致病潜力。这篇综述聚焦于这些问题,描述了所有GAD相关综合征更广泛的临床表现和重叠特征;阐述了GAD抗体滴度的重要性以及GAD表位的潜在意义;总结了自身免疫性过度兴奋的生物学基础;强调了肌肉僵硬中交互抑制的电生理基础;并提供了关于使用增强γ-氨基丁酸药物或各种免疫疗法进行症状治疗的实用指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d15a/8013924/f4210807f734/10.1177_17562864211003486-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d15a/8013924/d6b4fe7d46c9/10.1177_17562864211003486-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d15a/8013924/f4210807f734/10.1177_17562864211003486-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d15a/8013924/d6b4fe7d46c9/10.1177_17562864211003486-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d15a/8013924/f4210807f734/10.1177_17562864211003486-fig2.jpg

相似文献

1
GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.广泛性焦虑症抗体谱障碍:临床表型、免疫发病机制及治疗干预的进展
Ther Adv Neurol Disord. 2021 Mar 30;14:17562864211003486. doi: 10.1177/17562864211003486. eCollection 2021.
2
Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies.僵人综合征和 GABA 能神经元兴奋性、免疫发病机制及抗体治疗更新:广泛性焦虑症抗体谱障碍。
Neurotherapeutics. 2022 Apr;19(3):832-847. doi: 10.1007/s13311-022-01188-w. Epub 2022 Jan 27.
3
Stiff Person Syndrome and GAD Antibody-Spectrum Disorders.僵人综合征和 GAD 抗体谱障碍。
Continuum (Minneap Minn). 2024 Aug 1;30(4):1110-1135. doi: 10.1212/CON.0000000000001457.
4
Therapies in Stiff-Person Syndrome: Advances and Future Prospects Based on Disease Pathophysiology.僵人综合征的治疗:基于疾病病理生理学的进展和未来前景。
Neurol Neuroimmunol Neuroinflamm. 2023 Apr 14;10(3). doi: 10.1212/NXI.0000000000200109. Print 2023 May.
5
The neurological syndromes associated with glutamic acid decarboxylase antibodies.与谷氨酸脱羧酶抗体相关的神经综合征。
J Autoimmun. 2019 Jul;101:35-47. doi: 10.1016/j.jaut.2019.04.007. Epub 2019 Apr 15.
6
Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.僵人综合征患者血清和脑脊液中的抗谷氨酸脱羧酶抗体:与临床严重程度的相关性
Arch Neurol. 2004 Jun;61(6):902-4. doi: 10.1001/archneur.61.6.902.
7
Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.非副肿瘤性僵人综合征中的神经元表面和谷氨酸脱羧酶自身抗体。
JAMA Neurol. 2013 Sep 1;70(9):1140-9. doi: 10.1001/jamaneurol.2013.3499.
8
Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.与谷氨酸脱羧酶抗体相关的神经综合征谱系:这种关联的诊断线索
Brain. 2008 Oct;131(Pt 10):2553-63. doi: 10.1093/brain/awn183. Epub 2008 Aug 7.
9
Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response.谷氨酸脱羧酶抗体相关神经综合征:临床、抗体特征及治疗反应
J Neurol Sci. 2023 Feb 15;445:120540. doi: 10.1016/j.jns.2022.120540. Epub 2022 Dec 29.
10
Neurological Syndromes Associated with Anti-GAD Antibodies.与抗 GABA 抗体相关的神经综合征。
Int J Mol Sci. 2020 May 24;21(10):3701. doi: 10.3390/ijms21103701.

引用本文的文献

1
Coexistence of CN1A autoantibodies in GAD65 encephalitis exacerbates neurodegeneration : Novel autoantibodies in GAD65 encephalitis.GAD65 脑炎中 CN1A 自身抗体的共存会加剧神经退行性变:GAD65 脑炎中的新型自身抗体。
J Neuroinflammation. 2025 Jul 26;22(1):194. doi: 10.1186/s12974-025-03521-4.
2
Clonidine for the management of crises in stiff-person syndrome.可乐定用于治疗僵人综合征危象
J Neurol. 2025 Jul 1;272(7):485. doi: 10.1007/s00415-025-13226-6.
3
Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review.

本文引用的文献

1
Clinical spectrum of high-titre GAD65 antibodies.高滴度GAD65抗体的临床谱
J Neurol Neurosurg Psychiatry. 2021 Feb 9;92(6):645-54. doi: 10.1136/jnnp-2020-325275.
2
Limited Benefits Halt Enrollment in Hematopoietic Stem Cell Transplantation Trial for Stiff-Person Syndrome: Should There Be More to Come?益处有限导致僵人综合征造血干细胞移植试验停止招募:未来是否会有更多进展?
Neurology. 2021 Feb 9;96(6):239-240. doi: 10.1212/WNL.0000000000011349. Epub 2020 Dec 14.
3
Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial.
利妥昔单抗治疗伴谷氨酸脱羧酶65自身抗体的僵人综合征:一项系统评价
J Neurol. 2025 May 24;272(6):417. doi: 10.1007/s00415-025-13157-2.
4
Resolution of anti-GAD-associated autoimmune encephalitis in patients treated with efgartigimod.接受艾加莫德治疗的抗谷氨酸脱羧酶相关自身免疫性脑炎患者的病情缓解
Front Neurol. 2025 Apr 28;16:1550023. doi: 10.3389/fneur.2025.1550023. eCollection 2025.
5
Diverse clinical manifestations and management strategies in autoimmune polyglandular syndrome: a review of cases.自身免疫性多腺体综合征的多样临床表现及管理策略:病例综述
Ann Med Surg (Lond). 2025 Mar 28;87(5):2774-2783. doi: 10.1097/MS9.0000000000003207. eCollection 2025 May.
6
Anti-glutamic acid decarboxylase 65: Related stiff person syndrome - A report of two cases and literature review.抗谷氨酸脱羧酶65:相关性僵人综合征——两例报告及文献复习
SAGE Open Med Case Rep. 2025 Apr 29;13:2050313X251333676. doi: 10.1177/2050313X251333676. eCollection 2025.
7
Proposing Bromo-Epi-Androsterone (BEA) for Stiff Person Syndrome (SPS).提出将溴代表雄酮(BEA)用于僵人综合征(SPS)。
Microorganisms. 2025 Apr 5;13(4):824. doi: 10.3390/microorganisms13040824.
8
GAD65 Antibody-Associated Neurologic Syndrome Overlapping Hemophagocytic Lymphohistiocytosis.与65kD谷氨酸脱羧酶抗体相关的神经系统综合征重叠噬血细胞性淋巴组织细胞增生症
CNS Neurosci Ther. 2025 Mar;31(3):e70364. doi: 10.1111/cns.70364.
9
Immunogenetic Studies in Patients With GAD-Positive Stiff-Person Syndrome Reveal Novel Lymphocytic Genes and -Gene Variants.GAD 阳性僵人综合征患者的免疫遗传学研究揭示了新的淋巴细胞基因和基因变体。
Neurol Neuroimmunol Neuroinflamm. 2025 Mar;12(2):e200373. doi: 10.1212/NXI.0000000000200373. Epub 2025 Feb 11.
10
Coexistence of Anti-GAD and Anti-GABAAR Antibodies in an Autoimmune Encephalitis Patient: A Case Report.一名自身免疫性脑炎患者中抗谷氨酸脱羧酶抗体和抗γ-氨基丁酸A型受体抗体的共存:病例报告
Int Med Case Rep J. 2025 Jan 16;18:105-109. doi: 10.2147/IMCRJ.S488194. eCollection 2025.
自体造血干细胞移植治疗僵人综合征:一项临床试验。
Neurology. 2021 Feb 9;96(6):e817-e830. doi: 10.1212/WNL.0000000000011338. Epub 2020 Dec 14.
4
Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience.自体造血干细胞移植治疗难治性僵人综合征:英国经验。
J Neurol. 2021 Jan;268(1):265-275. doi: 10.1007/s00415-020-10054-8. Epub 2020 Aug 12.
5
GAD antibodies in neurological disorders - insights and challenges.神经疾病中的 GAD 抗体:研究进展与挑战。
Nat Rev Neurol. 2020 Jul;16(7):353-365. doi: 10.1038/s41582-020-0359-x. Epub 2020 May 26.
6
Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment.与抗 GAD65 相关的神经综合征:临床和血清学治疗反应。
Neurol Neuroimmunol Neuroinflamm. 2020 Mar 2;7(3). doi: 10.1212/NXI.0000000000000696. Print 2020 May.
7
Autoimmune musicogenic epilepsy associated with anti-glutamic acid decarboxylase antibodies and Stiff-person syndrome.与抗谷氨酸脱羧酶抗体及僵人综合征相关的自身免疫性音乐源性癫痫
Clin Case Rep. 2019 Dec 12;8(1):61-64. doi: 10.1002/ccr3.2538. eCollection 2020 Jan.
8
Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice.免疫球蛋白制剂中的抗神经元抗体:临床实践中的重要性。
Neurotherapeutics. 2020 Jan;17(1):235-242. doi: 10.1007/s13311-019-00796-3.
9
Abundant glutamic acid decarboxylase (GAD)-reactive B cells in gad-antibody-associated neurological disorders.在抗谷氨酸脱羧酶抗体相关神经疾病中存在大量谷氨酸脱羧酶反应性 B 细胞。
Ann Neurol. 2019 Mar;85(3):448-454. doi: 10.1002/ana.25414. Epub 2019 Jan 28.
10
Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder.僵人综合征的定量临床和自身免疫评估:一种进行性疾病的证据
BMC Neurol. 2019 Jan 3;19(1):1. doi: 10.1186/s12883-018-1232-z.